SCHEMBL8499230

SCHEMBL8499230

c1csc(-c2cnc3cncnc3n2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.59
HSD17B10 Q99714 8/20 0.59
CASP1 P29466 6/20 0.59
CASP7 P55210 6/20 0.59
NPC1 O15118 5/20 0.59
KDM4E B2RXH2 5/20 0.59
RAB9A P51151 4/20 0.59
HPGD P15428 4/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
GAA P10253 1/20 0.59
MAPK10 P53779 1/20 0.59
PDGFRB P09619 1/20 0.47
KIT P10721 1/20 0.47
FLT3 P36888 1/20 0.47
MEN1 O00255 7/20 0.45
KMT2A Q03164 7/20 0.45
CYP1A2 P05177 7/20 0.45
CYP3A4 P08684 6/20 0.45
CYP2C9 P11712 6/20 0.45
USP2 O75604 4/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10786959 0.88 ALDH1A1 (0.59) ALDH1A1HSD17B10CASP1CASP7NPC1
SCHEMBL6236262 0.79 CYP1A2 (0.56) ALDH1A1HSD17B10CASP1CASP7NPC1
SCHEMBL8503319 0.76 KDM4E (0.71) ALDH1A1HSD17B10CASP1CASP7NPC1
SCHEMBL8499783 0.75 ALDH1A1 (0.39) ALDH1A1HSD17B10CASP1CASP7NPC1
SCHEMBL708998 0.75 NPC1 (1.00) ALDH1A1HSD17B10CASP1CASP7NPC1
SCHEMBL31393433 0.75 NPC1 (1.00) ALDH1A1HSD17B10CASP1CASP7NPC1
SCHEMBL19066630 0.73 NPC1 (0.96) ALDH1A1HSD17B10CASP1CASP7NPC1
Ammonia Solution, Strong SCHEMBL28220789 0.72 NPC1 (0.93) ALDH1A1HSD17B10CASP1CASP7NPC1
SCHEMBL4376713 0.72 ADRA1D (0.40) ALDH1A1HSD17B10CASP1CASP7KDM4E
SCHEMBL8225185 0.72 CYP1A2 (0.49) ALDH1A1HSD17B10CASP1CASP7HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36256-E ADMINISTERING ARYL-SUBSTITUTED QUINOXALINE DERIVATIVES AS ANTIPROLIFERATIVE, ANTICARCINOGENIC AND ANTITUMOR AGENTS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-07-20 US disclosed
US-5795889-A INHIBITING CELL GROWTH WITH ENZYME INHIBITORS FOR SKIN DISORDERS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-08-18 US disclosed
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US disclosed
US-5480883-A Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-01-02 US disclosed